History
  • No items yet
midpage
Cupp Drug Store, Inc. v. Blue Cross & Blue Shield of Louisiana, Inc.
161 So. 3d 860
La. Ct. App.
2015
Read the full case

Background

  • Cupp sued Blue Cross for LUTPA-based damages after Blue Cross investigator Cowart disclosed concerns to Walgreens about Cupp’s sale to Walgreens, alleging unfair trade practices.
  • The jury found Cowart’s disclosures offended public policy and were unethical, oppressive, unscrupulous, or substantially injurious, awarding damages and attorney fees to Cupp.
  • Blue Cross appealed the LUTPA verdict, challenging the damages, and the supplemental judgment awarding attorney fees and costs.
  • There was significant conduct surrounding a potential Walgreens acquisition of Cupp, including internal memos, BOP prosecutions, and communications among Blue Cross, ESI, and Walgreens personnel.
  • Blue Cross sought to reverse or limit the LUTPA findings, while Cupp sought higher damages and fees on appeal.
  • The district court subsequently entered a supplemental judgment for costs and attorney fees, which the appellate court later vacated for lack of jurisdiction over those damages after suspensive appeal.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Cowart’s disclosure violated LUTPA. Cupp argues Cowart’s actions were unethical and injurious under LUTPA. Blue Cross contends the disclosure did not offend LUTPA public policy or constitute unfair practice. LUTPA violated; Cowart’s conduct upheld as unethical and injurious.
Whether the damages award of $185,000 was proper. Cupp contends damages should reflect the November sale terms and higher potential value. Blue Cross argues the record supports the $185,000 as justified damages. Damage award affirmed as not clearly wrong.
Whether the supplemental attorney fees/costs judgment was proper. Cupp seeks attorney fees for the LUTPA action on appeal. Blue Cross argues the district court lacked authority to amend final judgments for fees via a supplemental judgment. Supplemental judgment vacated; remanded for attorney fees and costs; $5,000 awarded for this appeal.
Whether the causation finding (Cowart’s disclosure causing Walgreens to back out) was supported. Cupp contends Cowart’s disclosure caused Walgreens to back away from the November deal. Blue Cross contends no causal link supported by the record. No manifest error; Cowart’s call caused Walgreens to back off the deal.
Whether the award of attorney fees on appeal is proper given suspensive appeal timing. Cupp seeks appellate fees related to defending LUTPA verdict. Blue Cross asserts lack of appellate-jurisdiction to award such fees. Fees for this appeal awarded; overall remand for ongoing fees and costs.

Key Cases Cited

  • Cheramie Servs. Inc. v. Shell Deepwater Prod. Inc., 35 So.3d 1053 (La. 2010) (LUTPA range is narrow; requires public-policy offense)
  • Stobart v. State through Dept. of Transp. & Dev., 617 So.2d 880 (La. 1993) (manifest-error standard for factual review)
  • Rosell v. ESCO, 549 So.2d 840 (La. 1989) (credibility and inferences should not be disturbed on review)
  • Turner v. Purina Mills Inc., 989 F.2d 1419 (5th Cir. 1993) (permissible business judgments and moral boundaries in LUTPA contexts)
  • Johnson Const. Co. v. Shaffer, 87 So.3d 203 (La. App. 2d Cir. 2012) (case-by-case LUTPA definition, unethical conduct elements)
Read the full case

Case Details

Case Name: Cupp Drug Store, Inc. v. Blue Cross & Blue Shield of Louisiana, Inc.
Court Name: Louisiana Court of Appeal
Date Published: Jan 7, 2015
Citation: 161 So. 3d 860
Docket Number: No. 49,482-CA
Court Abbreviation: La. Ct. App.